Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFα polymorphisms

International Journal of Colorectal Disease

Volumn 20, Issue 4, 2005, Pages 305-311

  Linderson, Ylva ^a,b   Bresso, Francesca ^a,b   Buentke, Eva ^b   Pettersson, Sven ^a,b   D'Amato, Mauro ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CARD15; Crohn's disease; Functional interaction; Polymorphism; TNF

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MURAMYL DIPEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL STRAIN HEK293; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE INDUCTION; GENE INTERACTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN POLYMORPHISM; PROTEIN SYNTHESIS;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; CELL CULTURE TECHNIQUES; CROHN DISEASE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21344438413     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-004-0732-z     Document Type: Article

References (41)

1. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417-429 10.1056/NEJMra020831
2. Bouma G, Strober W (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3:521-533 10.1038/nri1132
3. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S et al (2001) Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357:1925-1928 10.1016/S0140-6736(00)05063-7
4. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603 10.1038/35079107
5. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R et al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606 10.1038/35079114
6. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G (2001) Nod2 a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276:4812-4818
7. Inohara N, Nunez G (2003) NODs: Intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 3:371-382
8. Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, Tanabe T et al (2003) Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124:140-146
9. Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, Penard-Lacronique V, Sansonetti PJ, Hugot JP, Thomas G (2003) Gene - environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 100:3455-3460
10. Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT (1992) Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 339:89-91 10.1016/0140-6736(92)90999-J
11. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies. Immunity 10:387-398 10.1016/S1074-7613(00)80038-2
12. Neurath MF, Fuss I, Pasparakis M, Alexopoulou L, Haralambous S, Meyer zum Buschenfelde KH, Strober W, Kollias G (1997) Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 27:1743-1750
13. Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A (1997) Genetic influence on cytokine production in meningococcal disease. Lancet 349:1912-1913
14. Negoro K, Kinouchi Y, Hiwatashi N, Takahashi S, Takagi S, Satoh J, Shimosegawa T, Toyota T (1999) Crohn's disease is associated with novel polymorphisms in the 5'′-flanking region of the tumor necrosis factor gene. Gastroenterology 117:1062-1068 1:CAS:528:DyaK1MXnsVCqsbs%3D
15. Van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J et al (2002) Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet 11:1281-1289
16. Udalova IA, Richardson A, Denys A, Smith C, Ackerman H, Foxwell B, Kwiatkowski D (2000) Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol Cell Biol 20:9113-9119
17. Hohjoh H, Tokunaga K (2001) Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter. Genes Immun 2:105-109
18. Rosenstiel P, Fantini M, Brautigam K, Kuhbacher T, Waetzig GH, Seegert D, Schreiber S (2003) TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124:1001-1009
19. Huse B, Verca SB, Matthey P, Rusconi S (1998) Definition of a negative modulation domain in the human progesterone receptor. Mol Endocrinol 12:1334-1342
20. Schreiber E, Matthias P, Muller MM, Schaffner W (1989) Rapid detection of octamer binding proteins with 'mini-extracts' prepared from a small number of cells. Nucleic Acids Res 7:6419
21. Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705-716
22. Brass AL, Kehrli E, Eisenbeis CF, Storb U, Singh H (1996) Pip, a lymphoid-restricted IRF contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU1. Genes Dev 10:2335-2347
23. Chedid L (1983) Muramyl peptides as possible endogenous immunopharmacological mediators. Microbiol Immunol 27:723-732
24. Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, Prosper F, Nunez G, Fernandez-Luna JL (2002) Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 277:41701-41705
25. Li J, Moran T, Swanson E, Julian C, Harris J, Bonen DK et al. (2004) Regulation of IL-8 and IL-1β expression in Crohn's disease associated NOD2 /CARD15 mutations. Hum Mol Genet 13:1715-1725
26. Vermeire S, Louis E, Rutgeerts P, De Vos M, Van Gossum A, Belaiche J et al. (2002) NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology 123:106-111
27. Schreiber S, Nikolaus S, Hampe J (1998) Activation of NF-kappaB in inflammatory bowel disease. Gut 42:477-484
28. Van Deventer SJ (1997) Tumour necrosis factor and Crohn's disease. Gut 40:443-448 9176068
29. Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky DK (2003) CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124:993-1000
30. Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, Ogunbiyi O, Nunez G, Keshav S (2003) Crohn's disease and the NOD2 gene: A role for paneth cells. Gastroenterol 125:47-57
31. Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR et al (2003) The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 122:854-866; erratum125:281
32. Watanabe T, Kitani A, Murray PJ, Strober W (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5:800-808
33. Netea MG, Kullberg BJ, de Jong DJ, Franke B, Sprong T, Naber TH, Drenth JP, Van der Meer JW (2004) NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: Implications for Crohn's disease. Eur J Immunol 34:2052-2059
34. Louis E, Peeters M, Franchimont D, Seidel L, Fontaine F, Demolin G et al (2000) Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): Influence on disease behaviour? Clin Exp Immunol 119:64-68
35. Sashio H, Tamura K, Ito R, Yamamoto Y, Bamba H, Kosaka T et al. (2002) Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease respectively. Immunogenetics 53:1020-1027
36. Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP (2000) Cytokine (TNF alpha LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: Differential effects on production and allele frequencies. Genes Immun 1:185-190
37. Gonzalez S, Rodrigo L, Martinez-Borra J, Lopez-Vazquez A, Fuentes D, Nino P et al (2003) TNF-alpha - 308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease. Am J Gastroenterol 98 1101-1106
38. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A (1999) A common functional polymorphism (C→A substitution at position - 863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 8:1443-1449
39. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K (1998) Polymorphism of the 5'′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51:605-612 1:CAS:528:DyaK1cXks12ks70%3D
40. Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, McKenzie FE, Gribben JG, Hartl D, Yunis EJ, Goldfeld AE (1998) Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 52:359-367
41. Knight JC, Keating BJ, Rockett KA, and Kwiatkowski DP (2003) In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 33:469-475 10.1038/ ng1124